Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Organon & Co. Common Stock
(NY:
OGN
)
13.55
UNCHANGED
Official Closing Price
Updated: 7:00 PM EDT, Jul 31, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Organon & Co. Common Stock
< Previous
1
2
...
9
10
11
12
13
14
15
16
17
...
20
21
Next >
Organon & Lilly Expand Migraine Commercialization Agreement to 11 Additional Markets
August 20, 2024
From
Organon & Co.
Via
Business Wire
OGN Stock Earnings: Organon Beats EPS, Misses Revenue for Q2 2024
↗
August 06, 2024
OGN stock results show that Organon beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.
Via
InvestorPlace
Organon Reports Results for the Second Quarter Ended June 30, 2024
August 06, 2024
From
Organon & Co.
Via
Business Wire
Jim Cramer Says No To This Health Care Stock, Recommends Holding On To Constellation Energy: 'It's Up A Huge Amount'
↗
July 30, 2024
Jim Cramer said Constellation Energy is a "solar play that is a very good company. It's up a huge amount versus a lot of other stocks."
Via
Benzinga
High Dividend 50: Organon & Co.
↗
June 27, 2024
Organon & Co.’s current annual dividend is $1.12 per share. At around $20 per share, Organon stock has a high yield of 5.4%.
Via
Talk Markets
Thursday Is Your Last Chance To Buy Organon Before The Dividend Payout
↗
February 20, 2024
Via
Benzinga
Organon To Report Second Quarter 2024 Results and Host Conference Call on August 6, 2024
July 09, 2024
From
Organon & Co.
Via
Business Wire
3 High-Yield Dividend ETFs to Buy to Generate Passive Income
↗
July 06, 2024
These exchange-traded funds should keep the income flowing in regularly.
Via
The Motley Fool
Topics
ETFs
Value Investing Is Back! 3 Stocks With Strong Fundamentals to Buy Now
↗
June 26, 2024
Uncover three top value stocks to buy with robust fundamentals for stable long-term growth amid turbulence.
Via
InvestorPlace
3 Stocks With Mouthwatering Dividends You Can Buy Right Now
↗
June 08, 2024
These stocks offer great dividends and more.
Via
The Motley Fool
European Medicines Agency (EMA) Validates Henlius and Organon Filings for Prolia® and Xgeva® (denosumab) Biosimilar Candidate HLX14
May 24, 2024
From
Organon & Co.
Via
Business Wire
Wall Street's Most Accurate Analysts' Views On 3 Health Care Stocks With Over 5% Dividend Yields
↗
May 10, 2024
Via
Benzinga
Organon Announces Pricing of $1.0 Billion Senior Notes Offering
May 07, 2024
From
Organon & Co.
Via
Business Wire
Organon Announces Proposed $1.0 Billion Senior Notes Offering
May 07, 2024
From
Organon & Co.
Via
Business Wire
Organon Beats On Q1, Women's Health Leads the Charge
↗
May 02, 2024
Organon reported 5% increase in Q1 2024 revenue of $1.622 billion, beating consensus. EPS of $1.22 and dividend of $0.28 declared.
Via
Benzinga
OGN Stock Earnings: Organon Beats EPS, Beats Revenue for Q1 2024
↗
May 02, 2024
OGN stock results show that Organon beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via
InvestorPlace
Organon Reports Results for the First Quarter Ended March 31, 2024
May 02, 2024
From
Organon & Co.
Via
Business Wire
7 Sleeper Stocks to Buy Before Wall Street Wakes Up: April 2024
↗
May 01, 2024
While these sleeper stocks to buy don’t attract the spotlight, the lack of attention makes these ideas even more enticing.
Via
InvestorPlace
3 Healthcare Stocks With the Potential to Triple Your Investment by 2026
↗
May 01, 2024
Learn how these three healthcare stocks offer sharp opportunities in pharmaceuticals, healthcare services, and biotechnology.
Via
InvestorPlace
Organon To Report First Quarter 2024 Results and Host Conference Call on May 2, 2024
April 08, 2024
From
Organon & Co.
Via
Business Wire
Phase 3 Comparative Clinical Study of Prolia® and Xgeva® (denosumab) Biosimilar Candidate HLX14 Met Primary Endpoints
April 08, 2024
From
Organon & Co.
Via
Business Wire
Wall Street's Most Accurate Analysts' Views On 3 Health Care Stocks Delivering High-Dividend Yields
↗
March 13, 2024
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high...
Via
Benzinga
Turn $500 into a Fortune: 3 Top Stock Picks for March’s Million-Dollar Rally
↗
March 07, 2024
Here are three top stock picks for rally have their grip in travel, packaged foods, meats and pharmaceuticals.
Via
InvestorPlace
5 Value Stocks In The Healthcare Sector
↗
March 04, 2024
Via
Benzinga
Drug Maker Organon Stock Scores Relative Strength Upgrade
↗
February 28, 2024
In a welcome move, drug maker Organon stock saw its Relative Strength Rating rise from 66 to 71 on Wednesday.
Via
Investor's Business Daily
Under the Radar: 3 Overlooked Stocks Ready to Dominate the Market
↗
February 26, 2024
Explore growth strategies of overlooked stocks with strong fundamentals in strategic investments and market expansion.
Via
InvestorPlace
New York Attorney General Urges FDA Action On Widely Used Asthma Drug's Concerns Over Pediatric Safety
↗
February 26, 2024
The Attorney General of New York, Letitia James, has called on the FDA to address safety risks associated with the widely used asthma and allergy medicine Singulair (montelukast).
Via
Benzinga
Don't Overlook These Low-Risk High-Dividend Yielding Stocks
↗
February 24, 2024
Given the rally in the S&P 500 and the Nasdaq over the last year, it may be wise to consider stocks that should be less volatile during market corrections. Even better is when stocks have dividend...
Via
Talk Markets
Topics
Stocks
First Lady Jill Biden Unveils $100M In Federal Funding To Support R&D - Watch Out for These Women Health Stocks
↗
February 21, 2024
Jill Biden announces $100 million in federal funding for women's health research, addressing underfunding and lack of awareness. ARPA-H Sprint for Women's Health aims to promote innovative solutions.
Via
Benzinga
Organon Announces HADLIMA™ (adalimumab-bwwd) Has Been Exclusively Selected by the US Department of Veterans Affairs (VA), Replacing HUMIRA on Its National Formulary
February 20, 2024
From
Organon & Co.
Via
Business Wire
< Previous
1
2
...
9
10
11
12
13
14
15
16
17
...
20
21
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
